Fact CheckerSign in

NCT05874934Completed

Endoscopic Drainage of Presumed Resectable pCCA Using an Intrahepatic Plastic Stent With Retrieval String

Endoscopic Drainage of Presumed Resectable Perihilar Cholangiocarcinoma Using an Intrahepatic Plastic Stent With Retrieval String; a Pilot Study (CHORDA-II-pilot)

Source: ClinicalTrials.gov · Last updated 26 May 2026

Brief summary (registry, in English)

Prospective pilot study to assess the feasibility and efficacy of intrahepatic plastic biliary stents with a retrieval string in patients with presumed resectable perihilar cholangiocarcinoma requiring biliary drainage of the future liver remnant.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
16 Feb 2023
Start date
1 Mar 2023
Primary completion date
21 May 2026
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NCT number
NCT05874934

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 1 Mar 2023 to the primary completion date, 21 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Incompletely recovered from any side effects of previous biliary drainage procedures. Patients are required to be off antibiotic treatment for at least 5 days.
  • Any contra-indication for major liver surgery (e.g. ECOG/WHO score ≥3).
  • Technical contra-indications for endobiliary drainage (e.g. previous gastrojejunostomy).

Other

  • Distance between stricture and sphincter less than 2 cm.
  • Refusal to provide informed consent.

Who the study is looking for

  • 18 years or older.
  • Capable of providing written and oral informed consent.
  • Presumed perihilar cholangiocarcinoma.
  • Biliary obstruction in the future liver remnant.
  • Drainage naïve patients: total bilirubin \>50 umol/L
  • Patients with previous endobiliary drainage procedures: persistently rising total bilirubin \>50 umol/L (i.e. no stent placed or insufficient draining stent) or persistent biliary dilatation in the future liver remnant on imaging (i.e. previous stent placed in contralateral side of the liver).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Amsterdam UMC
Coordinator of this site? Confirm its status
AmsterdamNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.